Relationship Between T790M Allele Frequency and Therapeutic Effects Before and After EGFR‐TKI Administration Using Droplet Digital PCR in Non‐small‐cell Lung Cancer With EGFR Mutation
Compared with first-generation EGFR-TKI treatment, treatment with afatinib did not affect changes in the T/A ratio.
Authors
- Motohiro Tamiya (ORCID: https://orcid.org/0000-0001-6529-3092)
- Kenichi Minami
- Tomoya Kawaguchi (ORCID: https://orcid.org/0000-0002-7600-4847)
- Masaki Kanazu (ORCID: https://orcid.org/0000-0003-4405-1929)
- Yasuhiro Koh (ORCID: https://orcid.org/0000-0002-8758-8980)
- Yuki Sato (ORCID: https://orcid.org/0000-0003-2069-0355)
- Kenji Sawa
- Nobuhisa Ishikawa (ORCID: https://orcid.org/0000-0002-0208-2180)
- Hiroyasu Kaneda (ORCID: https://orcid.org/0000-0002-7696-2391)
- Koichi Ogawa
- Hidekazu Suzuki (ORCID: https://orcid.org/0000-0002-3855-3140)
- Yosuke Eguchi
- Yoshiya Matsumoto
Institutions
- Wakayama Medical University (JP)
- Ishikiriseiki Hospital (JP)
- Toneyama National Hospital (JP)
- Hiroshima Prefectural Hospital (JP)
- National Hospital Organization (JP)
- Osaka International Cancer Institute (JP)
- Kobe City Medical Center General Hospital (JP)
- Osaka Metropolitan University (JP)
- Tokyo Metropolitan University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-05-03
- DOI
- https://doi.org/10.21873/cdp.10441
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Bristol-Myers Squibb
- Pfizer
- Chugai Pharmaceutical